Testosterone optimization is one of the most-searched topics in men's health — and one of the most misunderstood. Here's what our clinical team sees most often, answered with current evidence and reviewed asynchronously at TelosRX, subject to medical approval by a licensed provider.
The questions below come from real search queries. If you've been trying to understand whether testosterone therapy makes sense for you, this is a clear starting point — no jargon, no sales pitch, just what the evidence shows. For more on the evaluation process itself, see our TRT telehealth guide.
What is testosterone optimization, and is it the same as TRT?
"TRT" (testosterone replacement therapy) is the clinical term for restoring testosterone to normal physiological ranges in men with documented hypogonadism. "Testosterone optimization" is broader: it includes both clinical replacement for diagnosed low testosterone and protocol-based management of suboptimal levels that may still fall within standard lab ranges but don't reflect optimal function for a given individual.
At TelosRX, the asynchronous intake process evaluates your symptoms, health history, and labs before any protocol is considered. Nothing is prescribed or dispensed without provider-issued review and approval.
What symptoms suggest low testosterone?
Low testosterone doesn't always present dramatically. Common signs include:
- Persistent fatigue or low energy not explained by sleep or thyroid issues
- Reduced libido or changes in sexual function
- Difficulty building or maintaining muscle despite consistent training
- Increased body fat — particularly midsection accumulation
- Mood changes: irritability, low motivation, or mild depression
- Brain fog or reduced cognitive sharpness
- Poor sleep quality or reduced deep-sleep stages
These symptoms overlap with many other conditions. Lab testing — total testosterone, free testosterone, LH, FSH, SHBG, and others — is part of the proper evaluation. See our related article on low testosterone and weight gain for more on the metabolic picture.
How does a provider evaluate someone for testosterone therapy?
A complete evaluation includes: symptom history, morning testosterone (total and free), SHBG, LH and FSH (to determine primary vs. secondary hypogonadism), hematocrit and CBC, and PSA for men over 40. Liver function and lipids are typically reviewed as well.
At TelosRX, this evaluation happens asynchronously. You submit your health history and labs; a licensed provider reviews the full picture and makes a clinical determination. No synchronous appointment is required. Subject to medical approval — approval is not guaranteed.
What forms of testosterone are used in compounded protocols?
Testosterone cypionate and testosterone enanthate are the most commonly compounded injectable esters. Both are well-studied, with established half-lives of approximately 7–10 days and 5–7 days respectively. Compounded testosterone is not FDA-approved and is prepared under federal compounding regulations.
FDA-approved commercial testosterone products (Androderm, Testim, Xyosted, and others) exist for diagnosed hypogonadism and may be prescribed through other clinical channels. The route of administration — injectable, transdermal cream/gel, or subcutaneous pellet — depends on your provider's clinical judgment and your individual preference.
How long until testosterone therapy produces results?
Timeline varies by individual. Most men notice improvements in energy and libido within 3–6 weeks. Meaningful body composition changes — increased lean mass, reduced fat — typically require 3–6 months with consistent protocol adherence and appropriate training. Lab markers like hematocrit reach new steady states around the 12-week mark.
A 2024 systematic review published in PMC (NCBI) found that TRT consistently improved sexual function and quality-of-life scores across clinical trials. Individual results vary. Outcomes are not guaranteed.
Is testosterone therapy safe for the heart?
This was the defining open question in hormone medicine for over a decade. The TRAVERSE trial resolved most of it. TRAVERSE enrolled 5,246 men with hypogonadism at high cardiovascular risk and followed them for approximately 4 years. The major adverse cardiovascular event rate was 7.0% in the testosterone group versus 7.3% in placebo — statistically non-inferior. In early 2025, the FDA removed the cardiovascular black-box warning from all testosterone products based on this data.
A thorough 2024 narrative review covering TRT in men 50 and older, available at PMC (NCBI), found no statistically significant increase in cardiovascular risk with properly monitored therapy. Hematocrit elevation remains the most clinically relevant safety parameter to monitor.
Does testosterone therapy affect fertility?
Yes — this must be discussed with your provider before starting. Exogenous testosterone suppresses LH and FSH through negative feedback on the hypothalamic-pituitary axis. This reduces intratesticular testosterone and suppresses sperm production. Fertility can be significantly impaired within weeks of starting therapy.
For men who want to preserve fertility, gonadorelin is commonly used to maintain LH stimulation during therapy. We covered this in detail in our Gonadorelin and TRT article. Disclosing fertility intentions to your provider before starting any protocol is essential.
What monitoring does a testosterone protocol require?
Proper monitoring includes the following labs and check-ins:
| Parameter | Why It Matters | Typical Frequency |
|---|---|---|
| Hematocrit | Elevated levels increase clotting risk; most providers target <54% | Every 8–12 weeks (first year) |
| Total and free testosterone | Confirms target range; guides dose adjustment | Every 8–12 weeks |
| PSA | Prostate safety; baseline required before starting | Annually for men 40+ |
| Estradiol | Testosterone aromatizes to estrogen; monitored for excess | As indicated by symptoms |
| Lipids and metabolic panel | Comprehensive metabolic overview | Annually or per provider guidance |
Your licensed provider sets the monitoring schedule. Once stable, check-in frequency typically decreases. Ready to start your evaluation? Begin your private review at TelosRX — our asynchronous intake captures the information your provider needs.
Frequently Asked Questions
Can I get testosterone therapy through an asynchronous telehealth service?
Yes. TelosRX operates as an online-first, asynchronous telehealth service. You submit your health history, symptoms, and labs; a licensed provider reviews them and makes a clinical determination. No synchronous appointment is required. Approval is not guaranteed — it depends on your full clinical picture and provider assessment.
Does TRT cause prostate cancer?
Current evidence does not support a causal link between TRT and prostate cancer in men without pre-existing disease. A 2024 systematic review in PMC found no statistically significant increase in prostate cancer incidence with properly monitored therapy. PSA monitoring before and during therapy is standard practice. Men with active or high-risk prostate cancer are not candidates for testosterone therapy.
What is considered a low testosterone level?
Most reference labs define low testosterone as below 300 ng/dL total testosterone — though ranges vary. Symptoms matter as much as numbers: a man with 290 ng/dL and significant symptoms presents very differently from one with 290 ng/dL and no complaints. Clinical evaluation considers total testosterone, free testosterone, SHBG, LH, and FSH together.
Can lifestyle changes raise testosterone naturally?
Yes, meaningfully in some cases. Resistance training, adequate sleep (7–9 hours), reducing excess body fat, managing chronic stress, and ensuring sufficient zinc and vitamin D intake all support endogenous testosterone production. For men with secondary hypogonadism partly driven by lifestyle factors, addressing those first makes clinical sense. For primary hypogonadism or significantly low levels, lifestyle changes alone rarely restore adequate testosterone.
Does TRT cause hair loss?
Testosterone therapy can accelerate androgenetic alopecia (male-pattern hair loss) in men who are genetically predisposed. Exogenous testosterone is converted to dihydrotestosterone (DHT) by 5-alpha reductase, and DHT drives follicle miniaturization in susceptible individuals. If hair retention is a concern, discuss it with your provider before starting any protocol.
What role does gonadorelin play in TRT?
Gonadorelin is a synthetic GnRH (gonadotropin-releasing hormone) analogue. Used alongside testosterone therapy, it maintains LH and FSH pulsatility — keeping testicular function active and preserving fertility potential. It may also help maintain testicular volume during therapy. Full overview: Gonadorelin for TRT.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.